Cross Town News
Cross Town News India Follow Editor Rahil Gupta on   Twitter   Instagram

AIIMS Delhi to start second dose trial of Bharat Biotech’s Covaxin on 2-6 years old children


Cinosural International An Elementry School Jammu

New Delhi, July 22: All India Institute of Medical Sciences in New Delhi will commence the second dose trial of Bharat Biotech's COVID-19 vaccine, Covaxin, for children aged 2-6 years.

Additionally, the results of clinical trials are expected to come in one month after the completion of trials of all age groups. 

 


   Popular News

Top